Form 4: Bicycle Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Michael Charles Ferguson Hannay, CHIEF PROD & SUPPLY CHAIN OFF of Bicycle Therapeutics Plc, sold 1,814 shares of common stock on October 2, 2026.
Summary
- Open-market sale: disposed of 1,572 Ordinary Shares at $3.47 ($5,455) on October 2, 2026; holds 92,803 after (Direct).
- Open-market sale: disposed of 242 Ordinary Shares at $3.57 ($864) on October 5, 2026; holds 92,561 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $6,319 of stock on the open market.
Insider Transactions
Michael Charles Ferguson Hannay — Officer (CHIEF PROD & SUPPLY CHAIN OFF)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Ordinary Shares | 1,572 | $3 | $5.5K | 92,803 |
| 2026-10-05 | Open-market sale | Ordinary Shares | 242 | $4 | $864 | 92,561 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (1,572 shares) |
| 2026-10-05 | Open-market sale (242 shares) |
Keywords
insider transaction, Form 4, BCYC, BICYCLE THERAPEUTICS PLC, bearish, Michael Charles Ferguson Hannay
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.